, Tracking Stock Market Picks
Enter Symbol:
Icad Inc. (ICAD) [hlAlert]

up 2.16 %

Icad Inc. (ICAD) rated Buy with price target $3.50 by Canaccord Adams

Posted on: Tuesday,  Dec 9, 2008  1:25 PM ET by Canaccord Adams

Canaccord Adams rated Buy Icad Inc. (NASDAQ: ICAD) on 12/09/2008. Previously Canaccord Adams rated Buy Icad Inc. (NASDAQ: ICAD) on 05/14/2008.,
when the stock price was $3.70. Since then, Icad Inc. has gained 2.16% as of 11/24/2015's recent price of $3.78.
If you would have followed the previous Canaccord Adams's recommendation on ICAD, you would have gained 2.16% of your investment in 2750 days.

iCAD, Inc. (iCAD) is a provider of computer-aided detection system (CAD) solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. CAD is performed as an adjunct to mammography screening. CAD is also reimbursable in the United States under federal and third party insurance programs. iCAD is also developing CAD solutions for use with virtual colonoscopy to improve the detection of colonic polyps while delivering improved workflow for the radiologists, and higher quality patient care. In July 2008, the Company acquired pharmaco-kinetic based CAD products that aid in the interpretation of contrast enhanced MRI images of the breast and prostate.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2008 1:25 PM Buy
1.40 3.50
as of 8/27/2015
1 Week up  20.00 %
1 Month up  2.43 %
3 Months down  -25.44 %
1 YTD down  -67.58 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/14/2008 11:25 AM Buy
3.70 4.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy